At a glance
ClinicalIndex Comparison RecordN/ACompleted· 43 enrolled
Drug / intervention
Experimental formula +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Hypoallergenicity of a Hydrolyzed Rice Protein-based Formula in Infants and Young Children With Cow's Milk Protein Allergy: a Randomized Nutritional Clinical Study
In Brief
A clinical study evaluating Experimental formula and Control formula for Cow's Milk Protein Allergy. Completed, enrolled 43 participants across 11 sites in 3 countries.
Detailed Summary
The purpose of the study is to determine whether a new hydrolyzed rice protein-based formula is hypoallergenic in infants and young children with documented Immunoglobulin E (IgE)-mediated Cow Milk Protein Allergy (CMPA).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCow's Milk Protein Allergy
CountriesGermany, Italy, Poland
Collaborators--
Timeline
N/ACompletedFinished
20252026
First PostedOct 2024
Enrollment StartNov 2024
Primary CompletionApr 2026
TodayJul 2026
First PostedOct 9, 2024
Enrollment StartNov 5, 2024
Primary CompletionApr 30, 2026
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 1.7 years ago
Interventions
Experimental formulaother
New hydrolyzed rice protein-based formula
Control formulaother
Commercially available amino acid-based formula.